Xconomy National

Archives

by in

Entry	Author	Date	Location
Marina Biotech Ends Bothell Lease on Nasal Spray Building, Coughs up Shares to Landlord	Luke Timmerman	10/04/11	Seattle
Case Closed on Mirina vs. Marina, as Accelerator Startup Changes Name	Luke Timmerman	06/22/11	Seattle
How Michael French, a Military Brat Turned Dealmaker, Kept Marina Biotech Alive	Luke Timmerman	12/20/10	Seattle
ProNAi Therapeutics Advances Gene-Silencing Cancer Drug, Marina Biotech Provides Delivery Package	Ryan McBride	09/28/10	Detroit
Lee Hood & Team Moving to South Lake Union, Mirina Vs. Marina, Trubion Gets Acquired, & More Seattle-Area Life Sciences News	Luke Timmerman	08/19/10	Seattle
Mirina Vs. Marina: The Looming Court Battle Over Biotech Company Names	Luke Timmerman	08/16/10	Seattle
New Startup ViThera Labs Aims “Weaponized” Bacteria Drugs at Gut Diseases	Ryan McBride	08/10/10	Boston
Immune Design Pockets $32M, InDi Nails $10M, SonoSite Looks Inside My Carotids, & More Seattle-Area Life Sciences News	Luke Timmerman	07/29/10	Seattle
Marina Gets RNAi Delivery Tools for $5M	Luke Timmerman	07/28/10	Seattle
Tekmira and AVI Win Ebola Deals, Mirador’s Idea to Prevent Hospital Errors, Tom Ranken’s New Mission, & More Seattle-Area Life Sciences News	Luke Timmerman	07/22/10	Seattle
MDRNA Does Reverse Stock Split	Luke Timmerman	07/21/10	Seattle
Who Needs VCs? Steven Quay’s Atossa Genetics Seeks Fast IPO For Breast Cancer Test	Luke Timmerman	05/21/10	Seattle
Sage Bionetworks On a Roll, Allon’s Foray into Alzheimer’s, Frazier Bets on Antibiotics, & More Seattle-Area Life Sciences News	Luke Timmerman	04/08/10	Seattle
SS&C Prices IPO, Amag Gets $60M from Takeda, Selecta Nabs $15M, & More Boston-Area Deals News	Erin Kutz	04/07/10	Boston
Jobster Gets New Owner, MDRNA Merges with Cequent and Teams Up with Pfizer, & More Seattle-Area Deals News	Gregory T. Huang	04/06/10	Seattle
MDRNA Gets Research Deal With Pfizer	Luke Timmerman	04/05/10	Seattle
Avila Gets Leukemia & Lymphoma Society Funding, Dicerna Unites with Ipsen, Rhythmia to Test Heart Mapping Technology, Amag Licenses to Takeda, & More Boston-Area Life Sciences News	Erin Kutz	04/02/10	Boston
MDRNA and Cequent Pharma in $46M Merger Deal	Ryan McBride	04/01/10	Seattle
FDA Panel Slams Cell Therapeutics, Oncothyreon Slumps, Biotech’s Healthcare Victory, & More Seattle-Area Life Sciences News	Luke Timmerman	03/25/10	Seattle
MDRNA Down to $1.7M Cash	Luke Timmerman	03/23/10	Seattle
A Brief Year-End Review of Seattle Biotech	Stewart Lyman	12/31/09	Seattle
MDRNA Grabs $1M Bridge Loan	Luke Timmerman	12/24/09	Seattle
AVI Biopharma Settles Into New Digs, Scopes Out Seattle Biotech Talent Pool	Luke Timmerman	09/29/09	Seattle
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009	Luke Timmerman	09/22/09	Seattle
Why Aren’t There Good Drugs for Autism? Ex-MDRNA Exec Takes a Shot at Pharma’s Neglected Disease	Luke Timmerman	09/14/09	Seattle
Cell Therapeutics Ships App to FDA, Targeted Genetics Cuts Again, Sanofi CEO Looks to Biotech & More Seattle Area Life Sciences News	Luke Timmerman	06/25/09	Seattle
Amazon Buys SnapTell, Madrona Backs Animoto, MDRNA Works Out Tech License, & More Seattle-Area Deals News	Gregory T. Huang	06/23/09	Seattle
MDRNA Gains Full Rights to Drug Technology	Luke Timmerman	06/19/09	Seattle
UW Stem Cell Startup is Born, Global Health’s “Davos” Arrives, MDRNA Unloads Debt, & More Seattle-Area Life Sciences News	Luke Timmerman	06/18/09	Seattle
MDRNA Pays Off $5.5M Debt	Luke Timmerman	06/16/09	Seattle
Page 1 of 2	next page »